Zobrazeno 1 - 10
of 91
pro vyhledávání: '"Sophie, Frantal"'
Autor:
Viktoria Knöbl, Lukas Maier, Stefan Grasl, Carmen Kratzer, Felix Winkler, Vanessa Eder, Hubert Hayden, Maria Amparo Sahagun Cortez, Monika Sachet, Rudolf Oehler, Sophie Frantal, Christian Fesl, Karin Zehetner, Georg Pfeiler, Rupert Bartsch, Florian Fitzal, Christian F. Singer, Martin Filipits, Michael Gnant, Christine Brostjan
Publikováno v:
Journal of Translational Medicine, Vol 22, Iss 1, Pp 1-15 (2024)
Abstract Background Monocytes comprise subsets of classical, intermediate and non-classical monocytes with distinct anti- or pro-tumor effects in breast cancer (BC). They are modulated by estrogen, and can contribute to BC control by endocrine therap
Externí odkaz:
https://doaj.org/article/67d59ab9099a49d8987574d7fbdf4ebb
Autor:
Kerstin Wimmer, Monika Sachet, Cristiano Ramos, Sophie Frantal, Hanna Birnleitner, Christine Brostjan, Ruth Exner, Martin Filipits, Zsuzsanna Bago-Horvath, Margaretha Rudas, Rupert Bartsch, Michael Gnant, Christian F. Singer, Marija Balic, Daniel Egle, Rudolf Oehler, Florian Fitzal
Publikováno v:
Journal of Experimental & Clinical Cancer Research, Vol 42, Iss 1, Pp 1-14 (2023)
Abstract Background Epirubicin/cyclophosphamide (EC) and docetaxel (D) are commonly used in a sequential regimen in the neoadjuvant treatment of early, high-risk or locally advanced breast cancer (BC). Novel approaches to increase the response rate c
Externí odkaz:
https://doaj.org/article/472702d7c4da4a55985a14b3016a1c91
Autor:
Gudrun Piringer MD, MSc, Bernhard Holzner MD, Beate Mayrbaeurl MD, Sonja Heibl MD, Monika Sztankay MD, Sophie Frantal, Michael Gnant MD, Josef Thaler MD
Publikováno v:
Integrative Cancer Therapies, Vol 19 (2020)
Purpose: Cancer and its treatment strategies can have adverse effects on physical functioning and quality of life. Treatment strategies for better quality of life are still an unresolved issue. Physical activity is a promising treatment strategy that
Externí odkaz:
https://doaj.org/article/cebf3090581c4a5cabefc18de1d78ab2
Autor:
Ellen Heitzer, Marija Balic, Michael Gnant, Martin Filipits, Nadia Dandachi, Sabrina Weber, Ricarda Graf, Anders Ståhlberg, Margaretha Rudas, Christian Fesl, Zsuzsanna Bago-Horvath, Peter C. Dubsky, Edgar Petru, Angelika Pichler, Viktor Wette, Rupert Bartsch, Georg Pfeiler, Daniel Egle, Christian F. Singer, Gabriel Rinnerthaler, Sophie Frantal, Simon P. Gampenrieder, Qing Zhou
Purpose:Accurate response assessment during neoadjuvant systemic treatment (NST) poses a clinical challenge. Therefore, a minimally invasive assessment of tumor response based on cell-free circulating tumor DNA (ctDNA) may be beneficial to guide trea
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::47ed243da79c1c37626cfbc7ae763edc
https://doi.org/10.1158/1078-0432.c.6532496
https://doi.org/10.1158/1078-0432.c.6532496
Autor:
Ellen Heitzer, Marija Balic, Michael Gnant, Martin Filipits, Nadia Dandachi, Sabrina Weber, Ricarda Graf, Anders Ståhlberg, Margaretha Rudas, Christian Fesl, Zsuzsanna Bago-Horvath, Peter C. Dubsky, Edgar Petru, Angelika Pichler, Viktor Wette, Rupert Bartsch, Georg Pfeiler, Daniel Egle, Christian F. Singer, Gabriel Rinnerthaler, Sophie Frantal, Simon P. Gampenrieder, Qing Zhou
Supplementary Figure from Persistence of ctDNA in Patients with Breast Cancer During Neoadjuvant Treatment Is a Significant Predictor of Poor Tumor Response
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::11bc36db6ecc63d35820191d0eb5f100
https://doi.org/10.1158/1078-0432.22487330
https://doi.org/10.1158/1078-0432.22487330
Autor:
Ellen Heitzer, Marija Balic, Michael Gnant, Martin Filipits, Nadia Dandachi, Sabrina Weber, Ricarda Graf, Anders Ståhlberg, Margaretha Rudas, Christian Fesl, Zsuzsanna Bago-Horvath, Peter C. Dubsky, Edgar Petru, Angelika Pichler, Viktor Wette, Rupert Bartsch, Georg Pfeiler, Daniel Egle, Christian F. Singer, Gabriel Rinnerthaler, Sophie Frantal, Simon P. Gampenrieder, Qing Zhou
Supplementary Table from Persistence of ctDNA in Patients with Breast Cancer During Neoadjuvant Treatment Is a Significant Predictor of Poor Tumor Response
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::5e466503ce14d784db53d6e97b43b5c0
https://doi.org/10.1158/1078-0432.22487306
https://doi.org/10.1158/1078-0432.22487306
Autor:
Christoph Minichsdorfer, Thorsten Fuereder, Michael Leutner, Christian F. Singer, Stephanie Kacerovsky-Strobl, Daniel Egle, Richard Greil, Marija Balic, Florian Fitzal, Georg Pfeiler, Sophie Frantal, Rupert A. Bartsch, Michael Gnant
Publikováno v:
Cancer Research. 82:P1-15
Background Statins are a common class of cholesterol-lowering drugs prescribed for the prevention and treatment of cardiovascular disease. Moreover, it was suggested that statins may possess anti-cancer properties and interact with RANK ligand expres
Autor:
Michael, Gnant, Amylou C, Dueck, Sophie, Frantal, Miguel, Martin, Hal J, Burstein, Richard, Greil, Peter, Fox, Antonio C, Wolff, Arlene, Chan, Eric P, Winer, Georg, Pfeiler, Kathy D, Miller, Marco, Colleoni, Jennifer M, Suga, Gabor, Rubovsky, Judith M, Bliss, Ingrid A, Mayer, Christian F, Singer, Zbigniew, Nowecki, Olwen, Hahn, Jacqui, Thomson, Norman, Wolmark, Kepa, Amillano, Hope S, Rugo, Guenther G, Steger, Blanca, Hernando Fernández de Aránguiz, Tufia C, Haddad, Antonia, Perelló, Meritxell, Bellet, Hannes, Fohler, Otto, Metzger Filho, Anita, Jallitsch-Halper, Kadine, Solomon, Céline, Schurmans, Kathy P, Theall, Dongrui R, Lu, Kathleen, Tenner, Christian, Fesl, Angela, DeMichele, Erica L, Mayer
Publikováno v:
Journal of Clinical Oncology. 40:282-293
PURPOSE Palbociclib is a cyclin-dependent kinase 4 and 6 inhibitor approved for advanced breast cancer. In the adjuvant setting, the potential value of adding palbociclib to endocrine therapy for hormone receptor–positive breast cancer has not been
Autor:
Zsuzsanna Bago-Horvath, Anders Ståhlberg, Christian F. Singer, Michael Gnant, Georg Pfeiler, Marija Balic, Christian Fesl, Edgar Petru, Nadia Dandachi, Sophie Frantal, Gabriel Rinnerthaler, Daniel Egle, Martin Filipits, Ellen Heitzer, Ricarda Graf, Simon Peter Gampenrieder, Viktor Wette, Sabrina Weber, Rupert Bartsch, Margaretha Rudas, Peter Dubsky, Angelika Pichler, Qing Zhou
Publikováno v:
Clinical Cancer Research. 28:697-707
Purpose: Accurate response assessment during neoadjuvant systemic treatment (NST) poses a clinical challenge. Therefore, a minimally invasive assessment of tumor response based on cell-free circulating tumor DNA (ctDNA) may be beneficial to guide tre
Autor:
Michael Gnant, Sophie Frantal, Georg Pfeiler, Guenther G. Steger, Daniel Egle, Richard Greil, Florian Fitzal, Viktor Wette, Marija Balic, Ferdinand Haslbauer, Elisabeth Melbinger-Zeinitzer, Vesna Bjelic-Radisic, Silvia Artner-Matuschek, Franz Kainberger, Magdalena Ritter, Gabriel Rinnerthaler, Paul Sevelda, Jonas Bergh, Stephanie Kacerovsky-Strobl, Christoph Suppan, Christine Brunner, Christine Deutschmann, Simon P. Gampenrieder, Hannes Fohler, Raimund Jakesz, Christian Fesl, Christian Singer
Publikováno v:
NEJM Evidence. 1